Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 24.10.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)46500THERACAP 131 TM (cps 1x370 MBq (púzdro))31.12.2024Z
 24.10.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)40649THERACAP 131 TM (cps 1x1332 MBq (púzdro))31.12.2024Z
 24.10.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)40680THERACAP 131 TM (cps 1x4,255 GBq (púzdro))31.12.2024Z
 24.10.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)40681THERACAP 131 TM (cps 1x4,440 GBq (púzdro))31.12.2024Z
 24.10.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)40682THERACAP 131 TM (cps 1x4,625 GBq (púzdro))31.12.2024Z
 24.10.2024GE Healthcare Buchler GmbH & Co. KG (GHB-1)40672THERACAP 131 TM (cps 1x2,590 GBq (púzdro))31.12.2024Z
 24.10.2024Sanofi Pasteur (SNP-F-8)0502CADACEL injekčná suspenzia naplnená v injekčnej striekačke (sus iru 1x0,5 ml (striek.inj.napl.+1 ihla))11.10.2024U
 23.10.2024Glenmark Pharmaceuticals s.r.o. (GLM-CZ)8993DDeferasirox Glenmark 180 mg filmom obalené tablety (tbl flm 30x180 mg (blis.Al/PVC/PVDC))1.12.2024Z
 23.10.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)2774BQuetiapin Sandoz 200 mg (tbl plg 60x200 mg (blis.PVC/PCTFE/Al))1.7.2020O
 23.10.2024Fresenius Kabi s.r.o. (FRK-CZ-3)2867ELacosamide Fresenius Kabi 10 mg/ml (sol inf 5x20 ml/200 mg (liek.inj.skl.))23.10.2024U
 23.10.2024Teva B.V. (TEV-NL-4)4749EDezmopresín Teva 120 mikrogramov sublingválne tablety (tbl slg 30x120 µg (blis.OPA/Al/PVC/PE-Al))20.11.2024Z
 23.10.2024Teva B.V. (TEV-NL-4)4771EDezmopresín Teva 60 mikrogramov sublingválne tablety (tbl slg 100x60 µg (blis.OPA/Al/PVC/PE-Al))30.1.2025Z
 23.10.2024Teva B.V. (TEV-NL-4)4767EDezmopresín Teva 60 mikrogramov sublingválne tablety (tbl slg 30x60 µg (blis.OPA/Al/PVC/PE-Al))15.11.2024Z
 23.10.2024Teva B.V. (TEV-NL-4)4753EDezmopresín Teva 120 mikrogramov sublingválne tablety (tbl slg 100x120 µg (blis.OPA/Al/PVC/PE-Al))15.11.2024Z
 22.10.2024Zentiva, k.s. (ZNT-1)7281CLopridam 4 mg/1,25 mg/5 mg (tbl 30x4 mg/1,25 mg/5 mg (blis.OPA/Al/PVC/Al))22.10.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)